BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 21, 2026
See today's BioWorld
Home
» Patent Reform Adds Value to Biotech's Intellectual Property
To read the full story,
subscribe
or
sign in
.
Patent Reform Adds Value to Biotech's Intellectual Property
March 10, 2011
By
Mari Serebrov
WASHINGTON – One of the intended casualties of the patent reform bill the Senate passed Tuesday is the years-long wait for the Patent and Trademark Office (PTO) to review a patent application.
BioWorld